| Literature DB >> 26278164 |
Boh-Ram Kim1, Eun-Ju Lee2, Seung Hee Seo1, Seung-Hoon Lee3, Seung Bae Rho4.
Abstract
In this study, we investigated a possible mechanism of β2-microglobulin (β2M) function in cancer metastases in vitro, using a human ovarian carcinoma cell line. β2M, a modulator acts as a cell growth-promoting and cellular signaling factors, was identified as a dickkopf-3 (DKK-3) interacting protein. We also observed that DKK-3 suppresses endothelial cell angiogenesis of β2M through vascular endothelial growth factor receptor-2 (VEGFR-2) in tumorigenesis. Luciferase activity was remarkably reduced by the transfection of DKK-3 in a dose-dependent manner. In addition, over-expression of β2M activates cell growth by suppressing DKK-3-induced apoptosis. The effect of β2M on cell cycle and apoptosis-regulatory components was also confirmed through the silencing of β2M expression. Furthermore, induction of β2M-mediated VEGFR-2/Akt/mTOR phosphorylation and tumor angiogenesis was significantly suppressed by over-expression of DKK-3. Taken together, our results suggest an underlying mechanism for an increase of β2M-related activity in ovarian tumor cells.Entities:
Keywords: Anti-apoptotic effect; DKK-3; Ovarian tumor metastasis; Protein–protein interaction; β2M
Mesh:
Substances:
Year: 2015 PMID: 26278164 DOI: 10.1016/j.cellsig.2015.08.008
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315